USD 5.5 billion deal: Biocon, an innovation-driven global biopharmaceuticals company, on Saturday, December 6 2025, announced a strategic move to fully integrate Biocon Biologics Limited (BBL) as a ...

(Reuters) -India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its ...

Biocon Share Price: Brokerage firm Jefferies is positive on the shares of Biocon Limited. The broking has upgraded the ...

** European Medicines Agency on Thursday accepted Biocon and U.S. drugmaker Mylan's regulatory submission for proposed breast cancer drug Sign up here. ** The submission could lead to approval of the ...